Emergency Use Authorizations

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 175 CE courses, most popular
$109Add to cart
Pick Your Courses
Up to 8 CE hours
$55Add to cart
Individual course$25Add to cart
Need multiple seats for your university or lab? Get a quote
The page below is a sample from the LabCE course Maintaining Compliance with Point-of-Care Testing. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Maintaining Compliance with Point-of-Care Testing (online CE course)
Emergency Use Authorizations

Point-of-care testing methods of all complexity levels are subject to the rigors of Food and Drug Administration (FDA) approval before utilization in the workplace. Specific scenarios in the healthcare industry require that diagnostic and direct patient care items be released before the completion of all evaluations included in the FDA evaluation process. The release of these products follows a process labeled Emergency Use Authorization (EUA). A EUA is described as a process whereby the "FDA may authorize unapproved medical products or unapproved uses of approved medical products to be used in an emergency to diagnose, treat, or prevent serious or life-threatening diseases.... when certain criteria are met including there are no adequate, approved, or available alternatives." (Emergency Use Authorization. www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization). EUA may be utilized for POCT methods under the above-described scenarios.
The test method or kit will be provided with written instructions and test complexity designation. The facilities utilizing the test methods must follow all written guidelines and requirements provided by the manufacturer.